Suppr超能文献

非酒精性脂肪性肝病、2 型糖尿病和肥胖之间的因果关系对疾病亚表型有影响。

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.

Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.

出版信息

J Hepatol. 2020 Aug;73(2):263-276. doi: 10.1016/j.jhep.2020.03.006. Epub 2020 Mar 10.

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D) and obesity are epidemiologically correlated with each other but the causal inter-relationships between them remain incompletely understood. We aimed to explore the causal relationships between the 3 diseases.

METHODS

Using both UK Biobank and publicly available genome-wide association study data, we performed a 2-sample bidirectional Mendelian randomization analysis to test the causal inter-relationships between NAFLD, T2D, and obesity. Transgenic mice expressing the human PNPLA3-I148M isoforms (TghPNPLA3-I148M) were used as an example to validate causal effects and explore underlying mechanisms.

RESULTS

Genetically driven NAFLD significantly increased the risk of T2D and central obesity but not insulin resistance or generalized obesity, while genetically driven T2D, body mass index and WHRadjBMI causally increased NAFLD risk. The animal study focusing on PNPLA3 corroborated these causal effects: compared to the TghPNPLA3-I148I controls, the TghPNPLA3-I148M mice developed glucose intolerance and increased visceral fat, but maintained normal insulin sensitivity, reduced body weight, and decreased circulating total cholesterol. Mechanistically, the TghPNPLA3-I148M mice demonstrated decreased pancreatic insulin but increased glucagon secretion, which was associated with increased pancreatic inflammation. In addition, transcription of hepatic cholesterol biosynthesis pathway genes was significantly suppressed, while transcription of thermogenic pathway genes was activated in subcutaneous and brown adipose tissues but not in visceral fat in TghPNPLA3-I148M mice.

CONCLUSIONS

Our study suggests that lifelong, genetically driven NAFLD causally promotes T2D with a late-onset type 1-like diabetic subphenotype and central obesity; while genetically driven T2D, obesity, and central obesity all causally increase the risk of NAFLD. This causal relationship revealed new insights into how nature and nurture drive these diseases, providing novel hypotheses for disease subphenotyping.

LAY SUMMARY

Non-alcoholic fatty liver disease, type 2 diabetes and obesity are epidemiologically correlated with each other, but their causal relationships were incompletely understood. Herein, we identified causal relationships between these conditions, which suggest that each of these closely related diseases should be further stratified into subtypes. This is important for accurate diagnosis, prevention and treatment of these diseases.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)、2 型糖尿病(T2D)和肥胖症在流行病学上相互关联,但它们之间的因果关系尚不完全清楚。我们旨在探讨这 3 种疾病之间的因果关系。

方法

利用英国生物银行(UK Biobank)和公开的全基因组关联研究数据,我们进行了 2 样本双向孟德尔随机化分析,以检验 NAFLD、T2D 和肥胖症之间的因果关系。我们使用表达人 PNPLA3-I148M 同工型的转基因小鼠(TghPNPLA3-I148M)作为示例来验证因果效应并探索潜在机制。

结果

遗传驱动的 NAFLD 显著增加了 T2D 和中心性肥胖的风险,但不增加胰岛素抵抗或全身性肥胖的风险,而遗传驱动的 T2D、体重指数和 WHRadjBMI 则可因果性地增加 NAFLD 的风险。针对 PNPLA3 的动物研究证实了这些因果关系:与 TghPNPLA3-I148I 对照相比,TghPNPLA3-I148M 小鼠发生葡萄糖不耐受和内脏脂肪增加,但保持正常的胰岛素敏感性、降低体重和降低循环总胆固醇。从机制上看,TghPNPLA3-I148M 小鼠表现出胰腺胰岛素减少但胰高血糖素分泌增加,这与胰腺炎症增加有关。此外,TghPNPLA3-I148M 小鼠肝脏胆固醇生物合成途径基因的转录显著受抑制,而皮下和棕色脂肪组织的产热途径基因的转录被激活,但内脏脂肪中的基因转录未被激活。

结论

本研究表明,终生遗传驱动的 NAFLD 可因果性地促进 T2D,表现为迟发性 1 型样糖尿病表型和中心性肥胖;而遗传驱动的 T2D、肥胖和中心性肥胖均会增加 NAFLD 的风险。这种因果关系为这些疾病的“天性”和“教养”如何驱动它们提供了新的见解,并为疾病的亚表型提供了新的假说。

非专业人士,仅供参考

相似文献

引用本文的文献

9

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验